Professor Shaun Treweek

Biography

Shaun is a professor and joined the Centre in 2013 via a meandering path to health services research.  He trained as a physicist and then did a bioengineering PhD involving lasers, blood and bits of skin.  Then came health informatics, amputee rehabilitation and a move to Oslo, followed by eight years at the University of Dundee, three of which as Assistant Director of the Tayside Clinical Trials Unit. 

Shaun is active in the field of efficient trial design, particularly pragmatic trial design, improved recruitment and retention interventions for trials, the design of complex interventions and the effective presentation of research evidence.  He is leading an initiative called Trial Forge (http://www.trialforge.org) that aims to be more systematic about how we generate and use research evidence in making trial design, conduct, analysis and reporting decisions.  

He is, or has been, involved in a range of trials, including an EC FP7 trial of treatments for a rare neuromuscular condition, a trial of a lifestyle intervention for women after pregnancy, a lifestyle change trial run through football clubs and the Scottish Premier League, a trial of nerve stilumation to improve continence among residents in care homes, a lifestyle change trial run through the Scottish breast screening program and a lung cancer screening trial.  Finally, he coordinated DECIDE, a 5-year, EC-funded project that aimed to improve the way guideline information is communicated to health professionals, patients and the public, policymakers and others.

Best email for contact is streweek@mac.com.

External Memberships

Funding committees

• Chair, Health Improvement, Protection and Services Committee, Chief Scientist Office, 2017 - 2021. Deputy Chair 2012 - 2017.
• External member of the Health Research Board - Ireland Clinical Trial Network Renewals Panel 2020-2021.
• External member of the Scottish Cancer Foundation Doctoral Training Fellowship award Panel 2020.
• Rapporteur and panel member for the European Cooperation in Science and Technology (COST) Program 2019.
• External member of the Health Research Board - Ireland/Interreg Cross-border Healthcare Intervention Trials in Ireland Network (CHITIN) Panel 2018. 

Advisory and other committees (current)

• Member, Policy and Research Committee (Scientific Advisor), Grampian Regional Equality Council (GREC), 2022- present.
• Member, Steering Committee for The People’s Review, University of Galway, 2022 - present.
• NCITA Prostate Cancer Global Trial Steering Committee, University College London, 2022 - present. 
• Scientific Advisor, Norwegian Centre for Epidemic Interventions Research, Oslo, Norway, 2021 - present.
• Chair, Trial planning subgroup of the NHS Research Scotland Restart Advisory Group ‘Data & Digital’ Working Group, 2021 - present.
• Member, Steering Committee for Ileostomy and Internal Pouch Association and Kingston Trust -funded study Hernia Active Living Trial (HALT), 2021 - present.
• Co-chair, MRC-NIHR Trial Methodology Research Partnership Inclusivity Subgroup, 2020 - present.
• Member, Scientific Advisory Committee NIHR Applied Research Collaboration (ARC) North East and North Cumbria, 2020 - present.
• Member, Advisory Group, NIHR-funded Research on Research Registry and Hub, 2020 - present.
• Chair, Steering Committee for NIHR funded study ‘Snacktivity’ to promote physical activity and reduce future risk of disease in the population (2019 – present).
• Member, International Advisory Board, Research Square (publisher), 2019 - 2022.
• Member, External Advisory Group for the North Wales Organisation for Randomised Trials in Health, 2019 - present.

Publishing

• Editor-in-Chief for Trials (2018 - present).

Prizes and Awards

Trial Forge won the 2019 Cochrane-REWARD Prize for reducing research waste (https://www.cochrane.org/news/2019-cochrane-reward-prize-winners-announced)

Research Overview

Randomised trials; Trial methodology; Trial efficiency; Inclusion in trials; Recruitment; Retention; Communicating research

Current Research

Some of the projects I’m involved with include:

• Trial Forge (http://trialforge.org).  A systematic approach to improving trial efficiency.
• ActWELL: a lifestyle change trial involving women attending routine breast screening in Scotland (http://www.actwellstudy.org).
• STEER: Systematic Techniques to Enhance Retention in RCTs.  Developing theory-informed ways to reduce loss-to-follow-up in trials.
• Making clinical trials more efficient: consolidating, communicating and improving knowledge of patient recruitment interventions.
• The DECIDE project (http://www.decide-collaboration.eu).  Improving the way guidelines are presented to users.
• Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose - see PRECIS-2 elaboration paper and protocol.
• OPTIMISTIC - Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve Stamina, a Target Identification Collaboration (http://optimistic-dm.eu)
• EuroFIT - improving men's health through healthy living programs delivered through football clubs (http://eurofitfp7.eu).
• The ECLS trial (http://www.eclsstudy.org): a trial evaluating the EarlyCDT-Lung blood test, which is designed to pick up lung cancer earlier, as part of a potential lung cancer screening program.
• The use of cardiac rehabilitation services to aid the recovery of colorectal cancer patients: A pilot randomised controlled trial (RCT) with embedded feasibility study - see protocol.
• Improving the normalisation of complex interventions: Developing quantitative measures for users based on Normalisation Process Theory (http://www.normalizationprocess.org)
• Systematic Techniques for Assessing Recruitment to Trials (START): a programme to test recruitment interventions (http://www.population-health.manchester.ac.uk/mrcstart/)
• A web-based platform to support the development-evaluation-implementation process of the 2008 MRC framework for developing and evaluating complex interventions(see protocol)
• Supporting the Use of Research Evidence (SURE) for Policy in African Health Systems (http://www.who.int/evidence/sure/en/)
• Football Fans in Training (FFIT): a randomized controlled trial of a gender-sensitive weight loss and healthy living programme delivered to men aged 35-60 by Scottish Premier League (SPL) football clubs (http://www.spl-ffit.co.uk/)

Funding and Grants

Selected grants

July 2022 (1/10/2022 - 30/9/2025)

531,674 CAD awarded by the Canadian Institutes of Health Research to Weijer, C, Taljaard M, Althabe F,  Binik A, Brehaut J, Eldridge S, Ferrand R, Gillies K, Giraudeau B, Goldstein C, Grimshaw J, Hemkens L, Hemming K, Johri, Kim S, Largent E, Leese J, London A, Magwood O, Marlin S, Mbuagbaw L, Mitchell S, Nicholls S, Petkovic J, Treweek S, Tugwell P, Welch V, van der Graaf R. for a project called ‘Ethical issues in cluster randomized trials: using stakeholder and patient engagement to generate guidance for the ethical design and conduct of trials evaluating clinical, health policy, health systems, and public health interventions.’ 

July 2022 (1/4/2023 - 31/3/27)

€370,000 awarded by Health Research Board to Shiely F, Loudon K, Nichol A, Taljaard M, Treweek S, Zwarenstein M for a study called ‘Development, validation and dissemination of the PRECIS-3 tool to support the design of pragmatic randomised controlled trials: Towards making clinical trials part of routine clinical care.’

April 2022 

£11,985 awarded by the NHS Grampian Endowment Fund to Gardner H, Treweek S, Wilson P, Thompson L, Rodgers, N, Murray C. for a study called ‘A qualitative interview study with adults living in remote and rural areas of Grampian to explore barriers and facilitators to participation in clinical trials.’

March 2022 

£1,625,150 awarded by NIHR to Parker A, Treweek S, Clarke M, Grimshaw J, Torgerson D for a project called ‘Using implementation science and Studies Within A Trial (IMPLEMENT SWATs) to improve evidence-based participant recruitment and retention in randomised controlled trials.’

January 2022 

AUS$149,402 awarded by the Australian National Health and Medical Research Council to Brijnath B, Gardner H, Ghersi D, Treweek S, Chan A-W, Orkin A, Welch V,     Owusu-Addo E, Nkrumah K. for a study called ‘Proposal for guidelines to improve the planning and reporting of variables related to ethnic diversity in RCTs, as an extension of the Standard Protocol Items: Recommendations for Interventional Trials.’ 

December 2021 (1/6/2022 - 31/5/2023)

€10,000 awarded by the Health Research Board Trial Methodology Research Network to Shiely F, Treweek S, Torgerson D, Dahly D, Crowley R, Clarke M, Murphy E, Briel M, Parker A, Gillies K, Weijer C for a project called ‘Trial Forge Guidance 3: Ethical issues in SWATs (Studies within a Trial).’ 

August 2021 (1/10/2021 - 30/9/2022)

£78,718 awarded by NIHR to Cooper C, Biggs K, Hancock H, Maier R, Shepherd V, Lane A, Torgerson D, Adamson J, Treweek S, Gardner H, Willis A, Isaacs T, Shiely F. for a study called ‘A collaborative study between CTUs and other researchers to identify the activities needed to improve representation of under-served groups in trials and understand their implementation.’

July 2021 (1/10/2021 - 30/9/2022)

£79,820 awarded by NIHR to Eldridge S, Lancaster G, Lawton S, Hopewell S, Treweek S, Gardner H, Jack A, Mohammed A, Jackson T for a study called ‘Promoting INCLUsivity through improving the practice anD utility of Ethnicity Data collection in trials (INCLUDED)’.

June 2021 (1/1/2022 - 31/5/2023)

£188,146 awarded by CSO to Treweek S, Gardner H, Gillies K, Witham M, Devane D, Khunti K, Bower P, Parker A, Oshisanya P, Soulsby I. for a study called ‘Improving ethnic diversity in trials: helping trial teams recruit and retain the ethnic groups essential for results with community-wide relevance and applicability.’

May 2021 (1/10/2021 - 30/9/2026)

€2,999,979 awarded by the Health Research Board to Devane D, Smith V, Dolan P, Shiely F, Toomey E, Treweek S. for a study called ‘HRB-TMRN Phase III Renewal 2021 – 2026’.

April 2021 (17/5/2021 - 16/9/2021

)£79,844 awarded by ESRC UKRI emergency COVID-19 funding to Treweek S, Brazzelli M, Isaacs T, Jack A, Kwaku-Odoi C, Bobat M, Durham C, Forde D, Mistry K, Rishi A. for a study called ‘Working with community groups to understand and reduce COVID-19 vaccine hesitancy among ethnic minority groups in the UK’

February 2021 (1/5/2021 - 30/4/2022)

£9,937 awarded by the MRC-NIHR Trial Methodology Research Partnership to Isaacs T, Treweek S, Finucane E, Gillies K, Noor N, Sydes M, Durand MA, Khunti K, Demjén Z, Burnett E, for a study called ‘Beyond "must speak English": In search of a fairer way to operationalise patient screening for language proficiency in trial recruitment.’

February 2021 (17/5/2021 - 31/10/2021)

£9,967 awarded by the MRC-NIHR Trial Methodology Research Partnership to Gardner H, Treweek S, Gillies K, Biesty L, Sohanpal R, Coffey T, Kearney A, Headlam I, Sopasay V, Antunes Batista da Silva F, Chaprana A, for a study called ‘Minority ExpeRiences In Trials (MERIT): Understanding why ethnic minority groups are under-represented in trials through a rapid qualitative evidence synthesis, and mapping evidence to find solutions.’

December 2020 (1/4/2021 - 30/11/2022)

£312,832 awarded by the MRC to Howick J, Hood K, Edwards A, Gillies K, Treweek S, Bower P.  for a study called ‘Developing and Testing Participant Information Leaflets (PILs) that Inform and do not Cause Harm (PrinciPILs)’

November 2020

€9,997 awarded to Shiely F, Isaacs T, Finucane E, Treweek S, Gillies K, O’Sullivan L for a study called ‘Understanding the language and complexity of informed consent in clinical trials and identifying participant preferences and understanding of key trial processes - randomisation.’